These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2062805)

  • 1. Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid.
    Badir K; Haj-Yehia A; Vree TB; van der Kleijn E; Bialer M
    Pharm Res; 1991 Jun; 8(6):750-3. PubMed ID: 2062805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of ester prodrugs of valproic acid.
    Hadad S; Vree TB; van der Kleijn E; Bialer M
    J Pharm Sci; 1992 Oct; 81(10):1047-50. PubMed ID: 1432619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid.
    Hadad S; Vree TB; van der Kleijn E; Bialer M
    Biopharm Drug Dispos; 1993 Jan; 14(1):51-9. PubMed ID: 8427944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
    Levi M; Yagen B; Bialer M
    Pharm Res; 1997 Feb; 14(2):213-7. PubMed ID: 9090712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid.
    Bialer M; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Shirvan M
    Biopharm Drug Dispos; 1996 Oct; 17(7):565-75. PubMed ID: 8894115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure.
    Gynther M; Peura L; Vernerová M; Leppänen J; Kärkkäinen J; Lehtonen M; Rautio J; Huttunen KM
    Neurochem Res; 2016 Oct; 41(10):2797-2809. PubMed ID: 27412117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valpromide, Valproic acid and removal of small intestine in the treatment of a chronic depression: a case report].
    Benjelloun G; Blandin K; Fossati P
    Encephale; 2004; 30(4):400-3. PubMed ID: 15538315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.
    Hönack D; Rundfeldt C; Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):187-96. PubMed ID: 1570023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we develop improved derivatives of valproic acid?
    Bialer M; Haj-Yehia A; Badir K; Hadad S
    Pharm World Sci; 1994 Feb; 16(1):2-6. PubMed ID: 8156045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
    Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
    Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disposition of valpromide in rats and the isolated perfused rat liver.
    Billig H; Ziv E; Bar-On H; Bialer M
    Drug Metab Dispos; 1990; 18(2):238-44. PubMed ID: 1971580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.
    Bialer M; Hadad S; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Yagen B
    Pharm Res; 1996 Feb; 13(2):284-9. PubMed ID: 8932450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
    Bialer M
    J Control Release; 1999 Nov; 62(1-2):187-92. PubMed ID: 10518650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
    Löscher W; Wahnschaffe U; Hönack D; Wittfoht W; Nau H
    Epilepsy Res; 1992 Dec; 13(3):187-98. PubMed ID: 1493781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of valproyl glycinamide and valproyl glycine in rats.
    Blotnik S; Bergman F; Bialer M
    Pharm Res; 1997 Jul; 14(7):873-8. PubMed ID: 9244143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid.
    Tang W; Palaty J; Abbott FS
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1163-72. PubMed ID: 9316822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats.
    Sobaniec W; Sobaniec-Lotowska M
    Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved gas chromatographic determination of valproic acid and valpromide in plasma.
    Pokrajac M; Miljković B; Spiridonović D; Varagić VM
    Pharm Acta Helv; 1992; 67(8):237-40. PubMed ID: 1409759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration.
    Dahan A; Duvdevani R; Shapiro I; Elmann A; Finkelstein E; Hoffman A
    J Control Release; 2008 Feb; 126(1):1-9. PubMed ID: 18082281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.